Beranda › Kanker Prostat › Tennessee
Uji klinis Kanker Prostat di Tennessee
49 studi untuk Kanker Prostat mencari peserta di lokasi di Tennessee.
Kota di Tennessee
Teks studi resmi (Bahasa Inggris)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Sarah Cannon Research Institute, Nashville
Menerima pesertaFase 1/2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04585750A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Sarah Cannon Research Institute, Nashville
- Tennessee Oncology PLLC, Nashville
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06465069A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- SCRI Oncology Partners, Nashville
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06172478Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Vanderbilt University/Ingram Cancer Center, Nashville
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT03866382A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Tennessee Oncology, Nashville
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 28 Sep 2026 · NCT06095089DESTINY-PANTUMOUR04
- Research Site, Nashville
Menerima pesertaStudi observasional
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07124000A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
- The Conrad Pearson Clinic, Germantown
Menerima pesertaFase 2
Usia 18 ke atas · Pria · Diperbarui 25 Sep 2026 · NCT07832292Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Sarah Cannon Research Institute, Nashville
- Urology Associates, Nashville
Menerima pesertaFase 1/2
Usia 18 ke atas · Pria · Diperbarui 25 Sep 2026 · NCT06800313A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- The West Clinic, PLLC dba West Cancer Center ( Site 0063), Germantown
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06136650This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Tennessee Oncology, PLLC - Chattanooga Downtown, Chattanooga
- Tennessee Oncology PLLC, Chattanooga
- Tennessee Oncology, PLLC - Chattanooga Med Park II, Chattanooga
- dan 20 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 24 Sep 2026 · NCT07028853A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
- Tennessee Oncology, Nashville
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 24 Sep 2026 · NCT07719361A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Sarah Cannon Research Institute Oncology Partners, Nashville
- United States Oncology Regulatory Affairs Corporate Office, Nashville
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 22 Sep 2026 · NCT07213674Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Tennessee Oncology PLLC, Chattanooga
Menerima pesertaFase 3
Usia 18 hingga 100 · Pria · Diperbarui 22 Sep 2026 · NCT06855277A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Nashville
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 18 Sep 2026 · NCT06952803A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
- GSK Investigational Site, Nashville
Menerima pesertaFase 1/2
Usia 18 ke atas · Pria · Diperbarui 18 Sep 2026 · NCT06990880High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- Memphis VA Medical Center, Memphis, TN, Memphis
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Menerima pesertaFase 2
Usia 18 ke atas · Pria · Diperbarui 17 Sep 2026 · NCT05011383Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC
- Sarah Cannon Research Institute, Nashville
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 17 Sep 2026 · NCT07813637A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Memphis VA Medical Center ( Site 0072), Memphis
- SCRI Oncology Partners ( Site 0074), Nashville
- Henry-Joyce Cancer Clinic ( Site 0042), Nashville
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 17 Sep 2026 · NCT06925737Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
- Sarah Cannon Research Institute Oncology Partners, Nashville
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 15 Sep 2026 · NCT07493512Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Urology Associates of Nashville, Nashville
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 11 Sep 2026 · NCT06056830A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- Sarah Cannon Research Center, Nashville
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06440005A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
- Sarah Cannon Research Institute, Nashville
Menerima pesertaFase 1/2
Usia 18 ke atas · Pria · Diperbarui 4 Sep 2026 · NCT07567846Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
- SCRI Oncology Partners, Nashville
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 3 Sep 2026 · NCT07545811A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
- Tennessee Oncology Nashville, Nashville
Menerima pesertaFase 2
Usia 18 ke atas · Pria · Diperbarui 3 Sep 2026 · NCT07005154AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Nashville
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 26 Agu 2026 · NCT07611110Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- Sarah Cannon Research Institute, Nashville
Menerima pesertaFase 2
Usia 18 ke atas · Pria · Diperbarui 24 Agu 2026 · NCT07745361Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- United States Oncology Regulatory Affairs Corporate Office, Nashville
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 21 Agu 2026 · NCT04221542A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Henry-Joyce Cancer Clinic, Nashville
Menerima pesertaFase 2
Usia 18 ke atas · Pria · Diperbarui 17 Agu 2026 · NCT06842498FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Sarah Cannon Research Institute, Nashville
- Vanderbilt Ingram Cancer Center, Nashville
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT05919264Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Sarah Cannon Research, Nashville
Menerima pesertaFase 1
Usia 18 hingga 100 · Pria · Diperbarui 13 Agu 2026 · NCT05519449Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
- Tennessee Oncology PLLC, Nashville
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT07288359Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
- Investigative Site #102, Nashville
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT06545942PSMA PET Combined With MRI for the Detection of PCa
- The Conrad Pearson Clinic, Germantown
- Urology Associates of Nashville, Nashville
Menerima pesertaFase 3Sukarelawan sehat diterima
Usia 18 ke atas · Pria · Diperbarui 23 Jul 2026 · NCT07052214Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Vanderbilt University/Ingram Cancer Center, Nashville
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 14 Jul 2026 · NCT06592924Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
- Sarah Cannon Research Institute, Nashville
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 2 Jul 2026 · NCT07140900International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- Memphis VA Medical Center, Memphis
- Baptist Clinical Research Institute, Memphis
Menerima pesertaStudi observasional
Usia 21 ke atas · Pria · Diperbarui 22 Mei 2026 · NCT03151629Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Sarah Cannon Research Institute, Nashville
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT06239194A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville
- Vanderbilt University Medical Center, Nashville
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Feb 2026 · NCT06778863A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
- Urology Associates PC, Nashville
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 4 Feb 2026 · NCT04729114Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- The West Clinic - Wolf River, Germantown
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 22 Jan 2026 · NCT06470243Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.